- Home
- WKC vs BCYC Comparison
WKC vs BCYC Comparison
Compare WKC & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKC
- BCYC
- Stock Information
- Founded
- WKC 1984
- BCYC 2009
- Country
- WKC United States
- BCYC United Kingdom
- Employees
- WKC N/A
- BCYC N/A
- Industry
- WKC Oil Refining/Marketing
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- WKC Energy
- BCYC Health Care
- Exchange
- WKC Nasdaq
- BCYC Nasdaq
- Market Cap
- WKC 1.7B
- BCYC 1.8B
- IPO Year
- WKC N/A
- BCYC 2019
- Fundamental
- Price
- WKC $29.00
- BCYC $24.91
- Analyst Decision
- WKC Hold
- BCYC Buy
- Analyst Count
- WKC 5
- BCYC 9
- Target Price
- WKC $28.00
- BCYC $42.00
- AVG Volume (30 Days)
- WKC 623.6K
- BCYC 341.8K
- Earning Date
- WKC 10-24-2024
- BCYC 10-31-2024
- Dividend Yield
- WKC 2.35%
- BCYC N/A
- EPS Growth
- WKC 20.89
- BCYC N/A
- EPS
- WKC 2.25
- BCYC N/A
- Revenue
- WKC $46,164,900,000.00
- BCYC $39,574,000.00
- Revenue This Year
- WKC N/A
- BCYC $59.17
- Revenue Next Year
- WKC $4.49
- BCYC N/A
- P/E Ratio
- WKC $12.89
- BCYC N/A
- Revenue Growth
- WKC N/A
- BCYC 75.74
- 52 Week Low
- WKC $17.69
- BCYC $12.54
- 52 Week High
- WKC $29.16
- BCYC $28.20
- Technical
- Relative Strength Index (RSI)
- WKC 58.31
- BCYC 71.66
- Support Level
- WKC $27.62
- BCYC $25.37
- Resistance Level
- WKC $29.16
- BCYC $28.20
- Average True Range (ATR)
- WKC 0.54
- BCYC 1.47
- MACD
- WKC -0.01
- BCYC 0.67
- Stochastic Oscillator
- WKC 70.69
- BCYC 90.65
About WKC World Kinect Corporation
World Kinect Corp is a energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers . It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. Company operate in three reportable segments consisting of aviation, land, and marine. Company earn majority of revenue from Aviation segment.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.